Results 1 to 10 of about 4,457,527 (301)

Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke [PDF]

open access: yesJournal of Stroke, 2013
Background and PurposeWidespread use of thrombolytic treatments, along with improved chances of survival after an initial ischemic stroke, increases the possibility of repeated thrombolysis. There are few reports, however, regarding repeated thrombolysis
Han Soo Yoo   +9 more
doaj   +2 more sources

Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review [PDF]

open access: yesThrombosis Journal, 2023
Cardiocerebrovascular diseases (CVDs) are the leading cause of death worldwide, consuming huge healthcare budget. For CVD patients, the prompt assessment and appropriate administration is the crux to save life and improve prognosis. Thrombolytic therapy,
Kexin Zhang   +3 more
doaj   +2 more sources

Recurrent high-risk pulmonary thromboembolism treated with repeated thrombolytic therapy could be helpful for certain patients: a case report and review of the literature [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2023
Acute pulmonary thromboembolism (PTE) is considered the third most frequent acute cardiovascular syndrome behind myocardial infarction and stroke, with annual incidence rates ranging from 39 to 115 per 100,000 people and ranking high among the causes of ...
Leila Bigdelu   +2 more
doaj   +2 more sources

Knowledge of thrombolytic therapy for acute ischemic stroke among community residents in western urban China. [PDF]

open access: yesPLoS ONE, 2014
Thrombolytic therapy rate for acute ischemic stroke remains low, and improving public awareness of thrombolytic therapy may be helpful to reduce delay and increase chances of thrombolytic therapy.
Juan Yang   +7 more
doaj   +1 more source

Thrombolytic therapy [PDF]

open access: yesHematology/Oncology Clinics of North America, 2002
The therapeutic use of thrombolytic agents is the natural result of the increasing understanding of the pathophysiologic mechanisms underlying normal and deranged thrombosis and fibrinolysis. Plasminogen activators capable of increasing the production of plasmin exhibit considerable efficacy in the treatment of a variety of arterial and venous ...
William F. Baker, William F. Baker
openaire   +3 more sources

The Effect of The Thrombolytic Treatment on Inflammatory Markers in Male Patients with Pulmonary Thromboembolism

open access: yesSakarya Tıp Dergisi, 2021
Objective: Neutrophil to lymphocyte (NLR) and platelet to lymphocyte (PLR) ratios play an important role in monitoring the progression of the disease and determining the course of the disease in patients with acute pulmonary thromboembolism (APTE).
Ayhan Coşgun, Hüseyin Ören
doaj   +1 more source

Study on the efficacy of compound porcine cerebroside and ganglioside injection in patients with ischemic stroke: A randomized, single‐center, open‐label, prospective study

open access: yesIbrain, EarlyView., 2023
Compound porcine perebroside and ganglioside injection (CPCGI) was used to treat ischemic stroke. However, there was no clinical evidence of low‐dose CPCGI. We conducted a clinical study to analyze whether the clinical results of low‐dose and standard‐dose CPCGI in patients with ischemic stroke were different.
Ya Chen   +8 more
wiley   +1 more source

Case report of repeat thrombolytic therapy in patient with acute circular-apical myocardial infarction, complicated anginous status

open access: yesЕвразийский Кардиологический Журнал, 2023
Presented clinical case report illustrates nonstandart approach use repeat thrombolytic therapy patient 49 y.o. with acute circular – apical myocardial infarction, after noneffective primary systemic thrombolytic therapy rtPA.
D. V. Bosikov   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy